Blue toe syndrome: treatment with percutaneous atherectomy

B L Dolmatch1, K S Rholl, L B Moskowitz

  • 1Miami Vascular Institute, Baptist Hospital, FL 33176.

Radiology
|December 1, 1989
PubMed

Insights

Percutaneous atherectomy effectively treats blue toe syndrome by removing emboli from superficial femoral artery lesions. This minimally invasive procedure resolves digital ischemia without surgery, offering histologic insights into embolic sources.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Dermatology

Background:

  • Blue toe syndrome (BTS) is characterized by digital ischemia despite palpable pedal pulses.
  • It results from microembolization to distal vessels from a proximal arterial source.
  • Superficial femoral artery (SFA) lesions are a common cause of embologenic BTS.

Purpose of the Study:

  • To evaluate the efficacy of percutaneous transluminal atherectomy (PTA) in treating embologenic SFA lesions in patients with BTS.
  • To assess the safety and outcomes of PTA in this patient population.
  • To investigate the histological composition of embolic material from SFA lesions.

Main Methods:

  • Seven patients with BTS underwent PTA for SFA stenosis.
  • Atherectomy devices were used to remove embologenic material.
  • Clinical outcomes, including resolution of ischemia and need for surgery, were monitored.
  • Histological analysis of atherectomy specimens was performed.

Main Results:

  • All seven patients experienced prompt healing of ischemic toes post-PTA.
  • No patient required surgical revascularization or amputation.
  • One patient had recurrent stenosis treated successfully with a larger atherectomy device.
  • Histology revealed fibrin-platelet aggregates and thrombus as primary embolic sources, with some cholesterol atheroma.

Conclusions:

  • Percutaneous atherectomy is an effective and safe treatment for embologenic SFA stenoses causing blue toe syndrome.
  • PTA offers nonsurgical removal of embolic material and provides diagnostic histological information.
  • This approach avoids surgical intervention and amputation in selected BTS patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...